ScoreWhy is Exelixis, Inc. ?
1
Strong Long Term Fundamental Strength with an average Return on Equity (ROE) of 13.05%
- Healthy long term growth as Net Sales has grown by an annual rate of 18.63%
- Company has a low Debt to Equity ratio (avg) at times
2
The company has declared Positive results for the last 6 consecutive quarters
- OPERATING CASH FLOW(Y) Highest at USD 884.27 MM
- ROCE(HY) Highest at 35.53%
- NET PROFIT(Q) Highest at USD 245.2 MM
3
With ROE of 31.57%, it has a attractive valuation with a 4.57 Price to Book Value
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 9.82%, its profits have risen by 71.1% ; the PEG ratio of the company is 0.2
4
High Institutional Holdings at 100%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
Real-Time Research ReportHow much should you buy?
- Overall Portfolio exposure to Exelixis, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Exelixis, Inc. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Exelixis, Inc.
5.45%
2.13
42.89%
S&P 500
17.78%
0.92
19.35%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
18.63%
EBIT Growth (5y)
51.99%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.48
Sales to Capital Employed (avg)
0.95
Tax Ratio
23.21%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
32.49%
ROE (avg)
13.05%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
14
Industry P/E
Price to Book Value
4.57
EV to EBIT
11.32
EV to EBITDA
10.89
EV to Capital Employed
6.85
EV to Sales
3.81
PEG Ratio
0.19
Dividend Yield
NA
ROCE (Latest)
60.51%
ROE (Latest)
31.57%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bearish
Dow Theory
No Trend
Mildly Bearish
OBV
No Trend
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend13What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD 884.27 MM
ROCE(HY)
Highest at 35.53%
NET PROFIT(Q)
Highest at USD 245.2 MM
RAW MATERIAL COST(Y)
Fallen by 0.94% (YoY
NET SALES(Q)
Highest at USD 598.66 MM
EPS(Q)
Highest at USD 0.88
-1What is not working for the Company
CASH AND EQV(HY)
Lowest at USD 2,047.63 MM
Here's what is working for Exelixis, Inc.
Operating Cash Flow
Highest at USD 884.27 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Net Profit
Highest at USD 245.2 MM and Grown
In each period in the last five periodsMOJO Watch
Near term Net Profit trend is very positive
Net Profit (USD MM)
Net Sales
Highest at USD 598.66 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (USD MM)
Net Profit
At USD 245.2 MM has Grown at 75.08%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is positive
Net Profit (USD MM)
EPS
Highest at USD 0.88
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (USD)
Raw Material Cost
Fallen by 0.94% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Exelixis, Inc.
Cash and Eqv
Lowest at USD 2,047.63 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
